Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

A siphon-like retrogastric transverse colon: A case report.

Harpain F, Gasché C, Prager G, Silberhumer GR.

Int J Surg Case Rep. 2018;44:110-113. doi: 10.1016/j.ijscr.2018.01.009. Epub 2018 Jan 31.

2.

Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia.

Frick A, Khare V, Paul G, Lang M, Ferk F, Knasmüller S, Beer A, Oberhuber G, Gasche C.

Mol Cancer Res. 2018 Apr;16(4):634-642. doi: 10.1158/1541-7786.MCR-17-0451. Epub 2018 Jan 29.

PMID:
29378905
3.

Identification of PMN-released mutagenic factors in a co-culture model for colitis-associated cancer.

Granofszky N, Lang M, Khare V, Schmid G, Scharl T, Ferk F, Jimenez K, Knasmüller S, Campregher C, Gasche C.

Carcinogenesis. 2018 Feb 9;39(2):146-157. doi: 10.1093/carcin/bgx118.

4.

HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.

Lang M, Berry D, Passecker K, Mesteri I, Bhuju S, Ebner F, Sedlyarov V, Evstatiev R, Dammann K, Loy A, Kuzyk O, Kovarik P, Khare V, Beibel M, Roma G, Meisner-Kober N, Gasche C.

Cancer Res. 2017 May 1;77(9):2424-2438. doi: 10.1158/0008-5472.CAN-15-1726. Epub 2017 Feb 20.

5.

Development of an index to define overall disease severity in IBD.

Siegel CA, Whitman CB, Spiegel BMR, Feagan B, Sands B, Loftus EV Jr, Panaccione R, D'Haens G, Bernstein CN, Gearry R, Ng SC, Mantzaris GJ, Sartor B, Silverberg MS, Riddell R, Koutroubakis IE, O'Morain C, Lakatos PL, McGovern DPB, Halfvarson J, Reinisch W, Rogler G, Kruis W, Tysk C, Schreiber S, Danese S, Sandborn W, Griffiths A, Moum B, Gasche C, Pallone F, Travis S, Panes J, Colombel JF, Hanauer S, Peyrin-Biroulet L.

Gut. 2018 Feb;67(2):244-254. doi: 10.1136/gutjnl-2016-312648. Epub 2016 Oct 25.

PMID:
27780886
6.

Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases.

Hou JK, Gasche C, Drazin NZ, Weaver SA, Ehrlich OG, Oberai R, Zapala S, Siegel CA, Melmed G.

Inflamm Bowel Dis. 2017 Jan;23(1):35-43. doi: 10.1097/MIB.0000000000000953.

PMID:
27749376
7.

[WMW special issue on iron metabolism].

Gasche C.

Wien Med Wochenschr. 2016 Oct;166(13-14):401. German. No abstract available.

PMID:
27600561
8.

On both sides of the ocean.

Jimenez K, Gasche C, Auerbach M.

Blood Transfus. 2016 May;14(2):197-8. doi: 10.2450/2016.0304-15. Epub 2016 Apr 28. No abstract available.

9.

Management of Iron Deficiency Anemia.

Jimenez K, Kulnigg-Dabsch S, Gasche C.

Gastroenterol Hepatol (N Y). 2015 Apr;11(4):241-50.

10.

PAK1 promotes intestinal tumor initiation.

Dammann K, Khare V, Harpain F, Lang M, Kurtovic A, Mesteri I, Evstatiev R, Gasche C.

Cancer Prev Res (Phila). 2015 Nov;8(11):1093-101. doi: 10.1158/1940-6207.CAPR-15-0205-T. Epub 2015 Aug 24.

11.

Quality of colonoscopy in Lynch syndrome.

Niv Y, Moeslein G, Vasen HF, Karner-Hanusch J, Lubinsky J, Gasche C; MesaCAPP Research Group.

Endosc Int Open. 2014 Dec;2(4):E252-5. doi: 10.1055/s-0034-1377920. Epub 2014 Oct 24.

12.

IL10R2 Overexpression Promotes IL22/STAT3 Signaling in Colorectal Carcinogenesis.

Khare V, Paul G, Movadat O, Frick A, Jambrich M, Krnjic A, Marian B, Wrba F, Gasche C.

Cancer Immunol Res. 2015 Nov;3(11):1227-35. doi: 10.1158/2326-6066.CIR-15-0031. Epub 2015 Jun 30.

13.

PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation.

Dammann K, Khare V, Lang M, Claudel T, Harpain F, Granofszky N, Evstatiev R, Williams JM, Pritchard DM, Watson A, Gasche C.

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2349-60. doi: 10.1016/j.bbamcr.2015.05.031. Epub 2015 May 31.

14.

Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer.

Shi C, Yang Y, Xia Y, Okugawa Y, Yang J, Liang Y, Chen H, Zhang P, Wang F, Han H, Wu W, Gao R, Gasche C, Qin H, Ma Y, Goel A.

Gut. 2016 Sep;65(9):1470-81. doi: 10.1136/gutjnl-2014-308455. Epub 2015 May 20.

PMID:
25994220
15.

On the safety of intravenous iron, evidence trumps conjecture.

Auerbach M, Adamson J, Bircher A, Breymann C, Fishbane S, Gafter-Gvili A, Gasche C, Gilreath J, Grazzini G, Henry D, Liumbruno G, Locatelli F, Macdougall I, Munoz M, Rampton D, Rodgers G, Shander A.

Haematologica. 2015 May;100(5):e214-5. doi: 10.3324/haematol.2014.121004. No abstract available.

16.

Increased expression of HIF2α during iron deficiency-associated megakaryocytic differentiation.

Jimenez K, Khare V, Evstatiev R, Kulnigg-Dabsch S, Jambrich M, Strobl H, Gasche C.

J Thromb Haemost. 2015 Jun;13(6):1113-27. doi: 10.1111/jth.12884. Epub 2015 Apr 23.

17.

Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.

Khare V, Dammann K, Asboth M, Krnjic A, Jambrich M, Gasche C.

Inflamm Bowel Dis. 2015 Feb;21(2):287-96. doi: 10.1097/MIB.0000000000000281.

18.

Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program.

Gasche C, Ahmad T, Tulassay Z, Baumgart DC, Bokemeyer B, Büning C, Howaldt S, Stallmach A; AEGIS Study Group.

Inflamm Bowel Dis. 2015 Mar;21(3):579-88. doi: 10.1097/MIB.0000000000000314.

19.

Chemoprevention of colorectal cancer.

Lang M, Gasche C.

Dig Dis. 2015;33(1):58-67. doi: 10.1159/000366037. Epub 2014 Dec 17. Review.

20.

European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.

Dignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, Gomollon F, Iqbal T, Katsanos K, Koutroubakis I, Magro F, Savoye G, Stein J, Vavricka S; European Crohn’s and Colitis Organisation [ECCO].

J Crohns Colitis. 2015 Mar;9(3):211-22. doi: 10.1093/ecco-jcc/jju009. Epub 2014 Dec 3. No abstract available.

PMID:
25518052
21.

Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia.

Iqbal T, Stein J, Sharma N, Kulnigg-Dabsch S, Vel S, Gasche C.

Dig Dis Sci. 2015 May;60(5):1375-81. doi: 10.1007/s10620-014-3460-4. Epub 2014 Dec 12.

22.

Vacuum inversion and securing of distal colonic pseudodiverticula with novel spiked O-rings.

Amato G, Birsan T, Granic E, Silberhumer G, Cassata G, Agrusa A, Puleio R, Romano G, Lang S, Noda W, Gasche C.

Gastrointest Endosc. 2015 Mar;81(3):749-55. doi: 10.1016/j.gie.2014.09.051. Epub 2014 Dec 5.

PMID:
25484325
23.

Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.

Kortüm B, Campregher C, Lang M, Khare V, Pinter M, Evstatiev R, Schmid G, Mittlböck M, Scharl T, Kucherlapati MH, Edelmann W, Gasche C.

Gut. 2015 Dec;64(12):1905-12. doi: 10.1136/gutjnl-2014-307663. Epub 2014 Nov 26.

24.

Republished: tracing PAKs from GI inflammation to cancer.

Dammann K, Khare V, Gasche C.

Postgrad Med J. 2014 Nov;90(1069):657-68. doi: 10.1136/postgradmedj-2014-306768rep.

25.

Endoscopic imaging of the vermiform appendix (with video).

Ferlitsch A, Puespoek A, Gasche C.

Gastrointest Endosc. 2014 Dec;80(6):1156-60. doi: 10.1016/j.gie.2014.07.048. Epub 2014 Oct 3.

PMID:
25281502
26.

Tracing PAKs from GI inflammation to cancer.

Dammann K, Khare V, Gasche C.

Gut. 2014 Jul;63(7):1173-84. doi: 10.1136/gutjnl-2014-306768. Epub 2014 May 7. Review. Erratum in: Gut. 2014 Aug;63(8):1368.

27.

Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study.

Favrat B, Balck K, Breymann C, Hedenus M, Keller T, Mezzacasa A, Gasche C.

PLoS One. 2014 Apr 21;9(4):e94217. doi: 10.1371/journal.pone.0094217. eCollection 2014.

28.

Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin.

Evstatiev R, Bukaty A, Jimenez K, Kulnigg-Dabsch S, Surman L, Schmid W, Eferl R, Lippert K, Scheiber-Mojdehkar B, Kvasnicka HM, Khare V, Gasche C.

Am J Hematol. 2014 May;89(5):524-9. doi: 10.1002/ajh.23682. Epub 2014 Feb 24.

29.

Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cells.

Khare V, Lang M, Dammann K, Campregher C, Lyakhovich A, Gasche C.

Biochem Pharmacol. 2014 Jan 15;87(2):312-20. doi: 10.1016/j.bcp.2013.10.021. Epub 2013 Oct 30.

30.

Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries.

Stein J, Bager P, Befrits R, Gasche C, Gudehus M, Lerebours E, Magro F, Mearin F, Mitchell D, Oldenburg B, Danese S.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1456-63. doi: 10.1097/MEG.0b013e328365ca7f.

PMID:
24100539
31.

Reply to Zuo et al.

Kulnigg-Dabsch S, Gasche C.

Inflamm Bowel Dis. 2013 Oct;19(11):E85-6. doi: 10.1097/MIB.0b013e3182a508b1. No abstract available.

PMID:
23962898
32.

[Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].

Angelberger S, Campregher C, Fuchssteiner H, Gasche C, Gröchenig HP, Haas T, Kazemi-Shirazi L, Mayer A, Miehsler W, Platzer R, Reinisch W, Steiner P, Tilg H, Tillinger W, Vogelsang H, Novacek G.

Z Gastroenterol. 2013 May;51(5):450-7. doi: 10.1055/s-0033-1335252. Epub 2013 May 16. German.

PMID:
23681899
33.

Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signaling.

Lang M, Borgmann M, Oberhuber G, Evstatiev R, Jimenez K, Dammann KW, Jambrich M, Khare V, Campregher C, Ristl R, Gasche C.

Mol Cancer. 2013 May 13;12(1):41. doi: 10.1186/1476-4598-12-41.

34.

Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).

Sebastian S, Hernández V, Myrelid P, Kariv R, Tsianos E, Toruner M, Marti-Gallostra M, Spinelli A, van der Meulen-de Jong AE, Yuksel ES, Gasche C, Ardizzone S, Danese S.

J Crohns Colitis. 2014 Jan;8(1):5-18. doi: 10.1016/j.crohns.2013.04.008. Epub 2013 May 9. Review.

PMID:
23664897
35.

Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial.

Kulnigg-Dabsch S, Schmid W, Howaldt S, Stein J, Mickisch O, Waldhör T, Evstatiev R, Kamali H, Volf I, Gasche C.

Inflamm Bowel Dis. 2013 Jul;19(8):1609-16. doi: 10.1097/MIB.0b013e318281f4db.

PMID:
23644823
36.

MSH3-deficiency initiates EMAST without oncogenic transformation of human colon epithelial cells.

Campregher C, Schmid G, Ferk F, Knasmüller S, Khare V, Kortüm B, Dammann K, Lang M, Scharl T, Spittler A, Roig AI, Shay JW, Gerner C, Gasche C.

PLoS One. 2012;7(11):e50541. doi: 10.1371/journal.pone.0050541. Epub 2012 Nov 27.

37.

Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1.

Khare V, Lyakhovich A, Dammann K, Lang M, Borgmann M, Tichy B, Pospisilova S, Luciani G, Campregher C, Evstatiev R, Pflueger M, Hundsberger H, Gasche C.

Biochem Pharmacol. 2013 Jan 15;85(2):234-44. doi: 10.1016/j.bcp.2012.10.026. Epub 2012 Nov 9.

38.

Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease.

Evstatiev R, Alexeeva O, Bokemeyer B, Chopey I, Felder M, Gudehus M, Iqbal T, Khalif I, Marteau P, Stein J, Gasche C; FERGI Study Group.

Clin Gastroenterol Hepatol. 2013 Mar;11(3):269-77. doi: 10.1016/j.cgh.2012.10.013. Epub 2012 Oct 16.

PMID:
23078888
39.

A randomized head-to-head study of small-bowel imaging comparing MiroCam and EndoCapsule.

Dolak W, Kulnigg-Dabsch S, Evstatiev R, Gasche C, Trauner M, Püspök A.

Endoscopy. 2012 Nov;44(11):1012-20. doi: 10.1055/s-0032-1310158. Epub 2012 Aug 28.

PMID:
22930176
40.

Inflammatory bowel disease.

Sachar DB, Jewell D, Gasche C, Braun J.

Int J Inflam. 2012;2012:341052. doi: 10.1155/2012/341052. Epub 2012 Mar 27. No abstract available.

41.

Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia.

Kulnigg-Dabsch S, Evstatiev R, Dejaco C, Gasche C.

PLoS One. 2012;7(4):e34520. doi: 10.1371/journal.pone.0034520. Epub 2012 Apr 10.

42.

Improvement of replication fidelity by certain mesalazine derivatives.

Honeder C, Campregher C, Zens B, Scharl T, Gasche C.

Int J Oncol. 2012 May;40(5):1331-8. doi: 10.3892/ijo.2012.1381. Epub 2012 Feb 21.

PMID:
22366868
43.

Aminosalicylates.

Campregher C, Gasche C.

Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):535-46. doi: 10.1016/j.bpg.2011.10.013. Review.

PMID:
22122769
44.

Iron sensing and signalling.

Evstatiev R, Gasche C.

Gut. 2012 Jun;61(6):933-52. doi: 10.1136/gut.2010.214312. Epub 2011 Oct 19. Review.

PMID:
22016365
45.

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.

Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C; FERGI Study Group.

Gastroenterology. 2011 Sep;141(3):846-853.e1-2. doi: 10.1053/j.gastro.2011.06.005. Epub 2011 Jun 12.

PMID:
21699794
46.

An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.

Finsterbusch M, Khare V, Campregher C, Evstatiev R, Gasche C.

Genes Immun. 2011 Oct;12(7):575-81. doi: 10.1038/gene.2011.12. Epub 2011 Jun 9.

47.

Inflamed gut mucosa: downstream of interleukin-10.

Paul G, Khare V, Gasche C.

Eur J Clin Invest. 2012 Jan;42(1):95-109. doi: 10.1111/j.1365-2362.2011.02552.x. Epub 2011 Jun 1. Review.

PMID:
21631466
48.

[Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party].

Gasche C, Evstatiev R, Haas T, Kaser A, Knoflach P, Petritsch W, Weiss G, Reinisch W.

Z Gastroenterol. 2011 May;49(5):627-32. doi: 10.1055/s-0031-1273324. Epub 2011 Apr 27. German.

PMID:
21526463
49.

Interaction of mesalasine (5-ASA) with translational initiation factors eIF4 partially explains 5-ASA anti-inflammatory and anti-neoplastic activities.

Lyakhovich A, Michlmayr A, Bakulina A, Gerner C, Oehler R, Gasche C.

Med Chem. 2011 Mar;7(2):92-8.

PMID:
21222616
50.

IL-10RA truncation mutations and Semite populations.

Gasche C, Reinisch W, Huber WD, Leshinsky-Silver E, Levine A, Abdul-Baki H, Sharara AI, Ajlouni Y, Sefiani A.

Inflamm Bowel Dis. 2011 Jun;17(6):1438. doi: 10.1002/ibd.21495. Epub 2010 Sep 14. No abstract available.

PMID:
20842643

Supplemental Content

Loading ...
Support Center